Clinical Trial Update: Pioglitazone Before Peginterferon and Ribavirin for Hepatitis C Infection in HIV/HCV-Coinfected Patients With Insulin Resistance [Phase 2]

View source ↗

Summary

Phase 2 trial assessing pioglitazone before peginterferon and ribavirin for Hepatitis C in HIV/HCV-coinfected patients with insulin resistance completed with re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Hepatitis C
• Insulin Resistance

Drugs mentioned

• PIOGLITAZONE (Pioglitazone)
• Peginterferon (Pegylated interferon)
• Ribavirin (ribavirin)

Snippet

Sponsor: Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections | Conditions: HIV-1 and Hepatitis C Co-Infection | Phase 2 | Status: COMPLETED | Results posted: 2012-09-13